Jaguar Health (JAGX) Restructuring Costs (2019)
Jaguar Health (JAGX) posted quarterly Restructuring Costs of $9000.0 for Q4 2019, down 98.59% quarter-over-quarter from $640000.0 in Q3 2019.
Jaguar Health (JAGX) Restructuring Costs (2019) Analysis & Trends
Jaguar Health (JAGX) has reported Restructuring Costs for 1 consecutive years, with $9000.0 the latest figure, recorded in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Jaguar Health | 448,735.56 | -9.62 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 9,000.00 |
| Sep 30, 2019 | 640,000.00 |